From: The role of radiotherapy in small cell carcinoma of the esophagus: a retrospective study
 | HR | 95%CI | P | HR | 95%CI | P |
---|---|---|---|---|---|---|
Age (≥ 60 vs. <60) | 1.385 | 1.037–1.848 | 0.027 |  |  |  |
Gender (Male vs. Female) | 0.998 | 0.752–1.325 | 0.991 |  |  |  |
Smoking history (Yes vs. No) | 1.343 | 1.020–1.769 | 0.036 | 1.335 | 1.010–1.765 | 0.042 |
Comorbidity (Yes vs. No) | 1.156 | 0.890–1.532 | 0.314 |  |  |  |
Ki67 (≤ 80%> vs. 80%) | 0.905 | 0.788–1.039 | 0.156 |  |  |  |
Syn (Positive vs. Negative) | 1.340 | 0.936–1.919 | 0.110 |  |  |  |
CgA (Positive vs. Negative) | 1.207 | 0.576–1.352 | 0.566 |  |  |  |
CD56 (Positive vs. Negative ) | 0.883 | 0.576–1.352 | 0.566 |  |  |  |
Surgery (Yes vs. No) | 0.544 | 0.412–0.718 | < 0.001 | 0.490 | 0.365–0.660 | < 0.001 |
Radiotherapy (Yes vs. No) | 0.941 | 0.720–1.231 | 0.657 | 0.711 | 0.533–0.949 | 0.020 |
Immunotherapy (Yes vs. No) | 0.820 | 0.506–1.330 | 0.422 |  |  |  |
Anti-angiogenic (Yes vs. No) | 0.958 | 0.625–1.469 | 0.843 |  |  |  |
Tumor location ( Middle thoracic vs. Others) | 0.915 | 0.701–1.195 | 0.514 |  |  |  |
TNM stage (I-II vs. III-IV) | 0.671 | 0.513–0.877 | 0.003 |  |  |  |